Benserazide Hydrochloride impurity C
95%
- Product Code: 80450
CAS:
1353749-74-2
| Molecular Weight: | 291.69 g./mol | Molecular Formula: | C₁₀H₁₄ClN₃O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, sealed, dry |
Product Description:
Benserazide Hydrochloride impurity C is primarily relevant in the pharmaceutical industry, where it is monitored during the production and quality control of Benserazide Hydrochloride, a drug used in combination with levodopa for the treatment of Parkinson's disease. The impurity is studied to ensure the safety, efficacy, and purity of the final drug product. Analytical methods are developed to detect and quantify this impurity, ensuring it remains within acceptable limits as per regulatory guidelines. Its presence is closely monitored to avoid potential adverse effects on patients and to maintain compliance with pharmaceutical standards. Research on this impurity also contributes to the optimization of manufacturing processes, helping to minimize its formation during synthesis.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | off-white solid |
| PURITY | 94.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | £226.17 |
+
-
|
| 0.500 | 10-20 days | £678.51 |
+
-
|
Benserazide Hydrochloride impurity C
Benserazide Hydrochloride impurity C is primarily relevant in the pharmaceutical industry, where it is monitored during the production and quality control of Benserazide Hydrochloride, a drug used in combination with levodopa for the treatment of Parkinson's disease. The impurity is studied to ensure the safety, efficacy, and purity of the final drug product. Analytical methods are developed to detect and quantify this impurity, ensuring it remains within acceptable limits as per regulatory guidelines. Its presence is closely monitored to avoid potential adverse effects on patients and to maintain compliance with pharmaceutical standards. Research on this impurity also contributes to the optimization of manufacturing processes, helping to minimize its formation during synthesis.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :